US Pharmaceuticals is a contract manufacturing organization (CMO), private label manufacturer and distributor of over-the-counter pharmaceuticals. Their products sell through major retail pharmacies — including Walgreens, Rite-Aid and CVS — as private label brands and through institutional healthcare distributors. Unaware that the availability of R&D tax credits that could help reduce the company’s tax liability was resulting in a missed opportunity to put money back into the business. Dinesh Patel, president, shares his story with ADP®.
Considering ADP’s extensive experience of IRS regulations and tax knowledge, I felt confident they could identify credit opportunities — if any — available for us.
- Unaware of qualifying R&D tax credits meant money was being left on the table that could be used to reinvest back into the company.
How ADP helped
- ADP’s team of experts was able to identify qualifying tax credits retroactively for three years and will help determine eligibility moving forward.